Adjuvant radiotherapy and chemotherapy in breast cancer: 30 year follow-up of survival

Bibliographic Details
Title: Adjuvant radiotherapy and chemotherapy in breast cancer: 30 year follow-up of survival
Authors: Greenlaw Nicola, McMillan Donald C, McArdle Colin S, Morrison David S
Source: BMC Cancer, Vol 10, Iss 1, p 398 (2010)
Publisher Information: BMC, 2010.
Publication Year: 2010
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Background The long term outcome (more than 15 years) of adjuvant treatment in patients with primary operable breast cancer has rarely been examined. Methods A randomised clinical trial of radiotherapy, chemotherapy (28 day cycles of cyclophosphamide, methotrexate and 5-fluorouracil) or both on women with primary operable breast cancer (n = 322) was followed-up for a median of 27 years. Results 260 (81%) patients died, 204 (78%) from breast cancer. Cancer specific survival (SE) at 10 years, 20 years and 30 years was 41 (3)%, 34 (3)% and 33 (3)% respectively. Presence of more than 3 involved lymph nodes increased cancer-specific mortality (HR 1.88, 95% CI 1.34-2.63) after adjustment for age, socio-economic deprivation and adjuvant treatment. Both age (HR 1.63, 95% CI 1.19-2.22) and involved lymph nodes (HR 1.59, 95% CI 1.17-2.14) were significant predictors of all-cause mortality after adjustment for other factors. There was no significant difference in all-cause or cancer-specific survival between patients in each of the 3 treatment arms. Conclusions The present study highlights the long term impact of node positive disease but does not indicate that any regimen was associated with significantly better long-term survival.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1471-2407
Relation: http://www.biomedcentral.com/1471-2407/10/398; https://doaj.org/toc/1471-2407
DOI: 10.1186/1471-2407-10-398
Access URL: https://doaj.org/article/dc0838a8bb224a588c5f950c53aba176
Accession Number: edsdoj.0838a8bb224a588c5f950c53aba176
Database: Directory of Open Access Journals
More Details
ISSN:14712407
DOI:10.1186/1471-2407-10-398
Published in:BMC Cancer
Language:English